Citius Pharmaceuticals, Inc.
CTXR
$0.968
-$0.021-2.12%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -9.77M | -10.79M | -10.57M | -8.54M | -9.23M |
| Total Depreciation and Amortization | 54.80K | 53.70K | 52.80K | 52.10K | 51.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.28M | 2.50M | 3.32M | 3.32M | 3.28M |
| Change in Net Operating Assets | 2.71M | 2.33M | -1.16M | -2.61M | -233.50K |
| Cash from Operations | -4.73M | -5.91M | -8.37M | -7.79M | -6.14M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -5.00M | -- | -- | -- |
| Cash from Investing | -- | -5.00M | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2.57M | 84.70K | 13.72M | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -3.83M | -- | -- | -- |
| Cash from Financing | 2.57M | -3.75M | 13.72M | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.15M | -14.66M | 5.35M | -7.79M | -6.14M |